Farmas USA

oido cocina

GILD velas 1 min

NVAX

No me gusta su comportamiento, ajeno hoy al IBB.

Veremos ...

edito: basta que lo diga para que suba, lo seguire a ver si sube mas :)

NVAX

Que ganas tengo de verla cerca de mi precio señorrrrrrr. Que te voy a contar a tí...

Novavax, Inc.

Novavax is already making preparations to commercialize its Respiratory Syncytial Virus (RSV) vaccine in the elderly since management anticipates positive top-line Phase 3 data this summer. In light of this positive outlook, analyst Heather Behanna of Wedbush recommends buying shares of the company during the recent market pullback and ahead of the pivotal data release.

The analyst explains, “Although there is inherent risk in commercializing the first RSV vaccine, we believe the flu vaccine sets a clear path forward.” In the flu season of 2014-2015, 67% of the elderly population received flu vaccines, according to CDC data. Behanna explains that the elderly population regularly visits physicians and are advised to get vaccinated.”

Behanna notes that potential commercialization success for the vaccine rests upon the recommendations from the Advisory Committee on Immunization Practices (ACIP). The analyst explains that the recommendation is only given to approved products, but Novavax is already working with the CDC and gathering relevant research to “begin a dialogue and to educate the ACIP on the need for RSV vaccination.” Ideally, Novavax’s RSV vaccine will launch ahead of the 2018 flu season.

Based on the positive outlook for the company’s RSV vaccine in the elderly, Behanna reiterated an Outperfrom rating on Novavax with a $14 price target on February 16. According to TipRanks, four other analysts currently has a buy rating on Novavax.

http://blog.tipranks.com/2016/02/biotech-insights-analysts-bullish-on-novavax-inc-nvax-and-neuralstem-inc-cur/

In HZNP 18,70 vamoossssssss trata de arracarlo por diossss trata de arrancarlo ... tan solo pido nuevos maximos intradia del IBB ... casi na ....

Jeje, al final entraste a porta gayola. Suerte! Yo estoy pensando poner todos los huevos en la misma cesta. Quito órden HZNP y pongo órden en NVAX a 5$. Paso de intras.

a porta gayola hubiera sido entrar a mercado en apertura ... bueno, vamos a ver como resulta porque el IBB se ha hecho nuevo maximo intradia 266,45 asi como si nada y luego parece que se ha arrepentido ... pero tengo confian"cilla" y sino siempre existe la amputacion

HZNP

NVAX sigo expectante ......cuanto más se distancie de los 4 mejor para todos....y eso requiere cerrar hoy por encima de 5....y nuestro querido IBB por encima de 260...